Aprepitant + Placebo to Aprepitant + Ondansetron + Placebo to match ondansetron
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Post-operative Nausea
Conditions
Post-operative Nausea, Post-operative Vomiting
Trial Timeline
Feb 12, 2013 → Sep 26, 2016
NCT ID
NCT01732458About Aprepitant + Placebo to Aprepitant + Ondansetron + Placebo to match ondansetron
Aprepitant + Placebo to Aprepitant + Ondansetron + Placebo to match ondansetron is a phase 2 stage product being developed by Merck for Post-operative Nausea. The current trial status is completed. This product is registered under clinical trial identifier NCT01732458. Target conditions include Post-operative Nausea, Post-operative Vomiting.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01732458 | Phase 2 | Completed |
Competing Products
18 competing products in Post-operative Nausea